Clinical Trial: Intra-Umbilical Vein Oxytocin Injection as an Adjunct to Active Management of the Third Stage of Labour

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07436286) titled 'Intra-Umbilical Vein Oxytocin Injection as an Adjunct to Active Management of the Third Stage of Labour' on Feb. 17.

Brief Summary: This randomized controlled clinical trial evaluates the effect of umbilical vein injection of oxytocin given in addition to routine active management of the third stage of labour. The third stage of labour is associated with a risk of postpartum haemorrhage, a major cause of maternal morbidity and mortality, particularly in low-resource settings. Active management with intramuscular oxytocin and controlled cord traction is standard practice, but additional measures that can further reduce blood loss may...